Skip to main content

Advertisement

SpringerLink
Log in

Guar Gum, Xanthan Gum, and HPMC Can Define Release Mechanisms and Sustain Release of Propranolol Hydrochloride

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The objectives were to characterize propranolol hydrochloride-loaded matrix tablets using guar gum, xanthan gum, and hydroxypropylmethylcellulose (HPMC) as rate-retarding polymers. Tablets were prepared by wet granulation using these polymers alone and in combination, and physical properties of the granules and tablets were studied. Drug release was evaluated in simulated gastric and intestinal media. Rugged tablets with appropriate physical properties were obtained. Empirical and semi-empirical models were fit to release data to elucidate release mechanisms. Guar gum alone was unable to control drug release until a 1:3 drug/gum ratio, where the release pattern matched a Higuchi profile. Matrix tablets incorporating HPMC provided near zero-order release over 12 h and erosion was a contributing mechanism. Combinations of HPMC with guar or xanthan gum resulted in a Higuchi release profile, revealing the dominance of the high viscosity gel formed by HPMC. As the single rate-retarding polymer, xanthan gum retarded release over 24 h and the Higuchi model best fit the data. When mixed with guar gum, at 10% or 20% xanthan levels, xanthan gum was unable to control release. However, tablets containing 30% guar gum and 30% xanthan gum behaved as if xanthan gum was the sole rate-retarding gum and drug was released by Fickian diffusion. Release profiles from certain tablets match 12-h literature profiles and the 24-h profile of Inderal® LA. The results confirm that guar gum, xanthan gum, and HPMC can be used for the successful preparation of sustained release oral propranolol hydrochoride tablets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

REFERENCES

  1. Snow V, Weiss K, Wall EM, Mottur-Pilson C. Pharmacologic management of acute attacks of migraine and prevention of migraine headaches. Ann Intern Med. 2002;137:840–9.

    PubMed  CAS  Google Scholar 

  2. Carroll JD, Reidy M, Savundra PA, Cleave N, McAinsh J. Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses. Cephalalgia. 1990;10:101–5.

    Article  PubMed  CAS  Google Scholar 

  3. Rajesh KS, Venkataraju MP, Gowda DV. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride. Pak J Pharm Sci. 2009;22:211–9.

    PubMed  CAS  Google Scholar 

  4. Rekhi GS, Porter SC, Jambhekar SS. Factors affecting the release of propranolol hydrochloride from beads coated with aqueous polymeric dispersion. Drug Dev Ind Pharm. 1995;21:709–12.

    Article  CAS  Google Scholar 

  5. Sahoo J, Murthy PN, Biswal S, Sahoo SK, Mahapatra AK. Comparative study of propranolol hydrochloride release with Kollidon®SR or hydroxypropylmethyl cellulose. AAPSPharmSciTech. 2008;9(2):577–82.

    CAS  Google Scholar 

  6. Dabbagh MA, Ford JL, Rubinstein MH, Hogan JE, Rajabi-Siahboomi AR. Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethyl cellulose and hydroxypropylmethyl cellulose. Pharm Dev Technol. 1999;4(3):313–24.

    Article  PubMed  CAS  Google Scholar 

  7. Velasco-De-Paola MVR, Santoro MIRM, Gai MN. Dissolution kinetics evaluation of controlled-release tablets containing propranolol hydrochloride. Drug Dev Ind Pharm. 1999;25:535–41.

    Article  PubMed  CAS  Google Scholar 

  8. Ford JL, Rubinstein MH, Hogan JE. Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropylmethylcellulose. Int J Pharm. 1985;24:339–50.

    Article  CAS  Google Scholar 

  9. McAinsh J, Baber NS, Holmes BF, Young J, Ellis SH. Bioavailability of sustained release propranolol formulations. Biopharm Drug Dispos. 1981;2:39–48.

    Article  PubMed  CAS  Google Scholar 

  10. Ravi PR, Kotreka UK, Saha RN. Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics. AAPS Pharm SciTech. 2008;9(1):302–13.

    Article  CAS  Google Scholar 

  11. Verhoeven E, Vervaet C, Remon JP. Xanthan gum to tailor drug release of sustained-release Ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2006;63:320–30.

    Article  PubMed  CAS  Google Scholar 

  12. Tahara K, Yamamoto K, Nishihata T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J Control Rel. 1995;35:59–66.

    Article  CAS  Google Scholar 

  13. Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulations. Eur J Pharm Sci. 1998;6:207–17.

    Article  PubMed  CAS  Google Scholar 

  14. Baveja SK, Ranga Rao KV, Padmalatha Devi K. Zero-order release hydrophilic matrix tablets of β-adrenergic blockers. Int J Pharm. 1987;39:39–45.

    Article  CAS  Google Scholar 

  15. Ranga Rao KV, Padmalatha Devi K, Buri P. Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J Control Rel. 1990;12:133–41.

    Article  Google Scholar 

  16. Kotadiya R, Patel V, Patel H. Comparative evaluation study of matrix properties of natural gums and semi-synthetic polymer. J Pharm Res. 2008;1:208–14.

    Google Scholar 

  17. Dhopeshwarkar V, Zatz JL. Evaluation of xanthan gum in the preparation of sustained release matrix tablets. Drug Dev Ind Pharm. 1993;19:999–1017.

    Article  CAS  Google Scholar 

  18. Al-Saidan SM, Krishnaiah YSR, Patro SS, Satyanaryana V. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride. AAPSPharmSciTech. 2005;6(1):E14–21.

    Google Scholar 

  19. Chaplin M. Water structure and behavior: guar gum. London: South Bank University; 2006.

    Google Scholar 

  20. Altaf SA, Yu K, Parasrampuria J, Friend DR. Guar gum based sustained release diltiazem. Pharm Res. 1998;15:1196–201.

    Article  PubMed  CAS  Google Scholar 

  21. Khullar P, Khar RK, Agarwal SP. Evaluation of guar gum in the preparation of sustained release matrix tablets. Drug Dev Ind Pharm. 1998;24:1095–9.

    Article  PubMed  CAS  Google Scholar 

  22. Krishnaiah YSR, Karthikeyan RS, GouriSankar V, Satyanarayana V. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J Control Rel. 2002;81:45–56.

    Article  CAS  Google Scholar 

  23. Varshosaz J, Tavakoli N, Kheirolahi F. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS PharmSciTech. 2006; 7(1): Article 24.

    Google Scholar 

  24. Ford JL, Rubinstein MH, Hogan JE. Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl-methylcellulose matrices. Int J Pharm. 1985;24:327–38.

    Article  CAS  Google Scholar 

  25. Wan LSC, Heng PWS, Wong LF. Relationship between swelling and drug release in a hydrophilic matrix. Drug Dev Ind Pharm. 1993;19:1201–10.

    Article  CAS  Google Scholar 

  26. Merchant HA, Shoaib HM, Tazeen J, Yousuf RI. Once-Daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech. 2006; 7(3): Article 78.

    Google Scholar 

  27. Lapidus H, Lordi NG. Drug release from compressed hydrophilic matrices. J Pharm Sci. 1968;57:1292–301.

    Article  PubMed  CAS  Google Scholar 

  28. Lapidus H, Lordi NG. Some factors affecting the release of a water soluble drug from a compressed hydrophilic matrix. J Pharm Sci. 1966;55:840–3.

    Article  PubMed  CAS  Google Scholar 

  29. Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Release characteristics of diclofenac sodium from encapsulated natural gum mini-matrix formulations. Int J Pharm. 1996;139:53–62.

    Article  CAS  Google Scholar 

  30. Solinís MA, De La Cruz Y, Calvo B, Hernández RM, Gascón AR, Goñi I, et al. Release of salbutamol sulfate and ketoprofen enantiomers from matrices containing HPMC and cellulose derivatives. Chirality. 2002;14:806–13.

    Article  PubMed  Google Scholar 

  31. Talukdar MM, Kinget R. Comparative study on xanthun gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery. II. Drug diffusion in hydrated matrices. Int J Pharm. 1997;151:99–107.

    Article  CAS  Google Scholar 

  32. Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm. 1989;57:169–72.

    Article  CAS  Google Scholar 

  33. Raja Sekharan T, Palanichamy S, Shanmuganathan S, Karthikeyan A, Senthilkumar SR, Thanga Thirupathi A. Formulation and evaluation of theophylline controlled release matrix tablets using xanthan gum. Der Pharmacia Lettre. 2009;1:93–101.

    Google Scholar 

  34. Mohammadi-Samani S, Adrangui M, Siahi-Shadbad MR, Nokhodchi A. An approach to controlled-release dosage form of propranolol hydrochloride. Drug Dev Ind Pharm. 2000;26:91–4.

    Article  PubMed  CAS  Google Scholar 

  35. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note. AAPS PharmSciTech. 2007; 8(1): Article 13.

  36. Kumar V, Kothari SH, Banker GS. Compression, compaction, and disintegration properties of low crystallinity celluloses produced using different agitation rates during their regeneration from phosphoric acid solutions. AAPS PharmSciTech. 2001; 2(2): Article 7.

  37. Carr RL. Classifying flow properties of solids. Chem Eng. 1965;72:69–72.

    CAS  Google Scholar 

  38. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.

    Article  CAS  Google Scholar 

  39. Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Rel. 1987;5:23–36.

    Article  CAS  Google Scholar 

  40. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–9.

    Article  PubMed  CAS  Google Scholar 

  41. Higuchi T. Release rate of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50:874–5.

    Article  PubMed  CAS  Google Scholar 

  42. Desai SJ, Simonelli AP, Higuchi WI. Investigation of factors influencing release of solid drug dispersed in inert matrices. J Pharm Sci. 1965;54:1459–64.

    Article  PubMed  CAS  Google Scholar 

  43. Carstensen JT. Pharmaceutical principles of solid dosage forms. Lancaster: Technomic; 1993.

    Google Scholar 

  44. Siepmann J, Peppas NA. Mathematical modeling of controlled drug delivery. Adv Drug Deliv Rev. 2001;48:137–8.

    Article  PubMed  CAS  Google Scholar 

  45. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139–57.

    Article  PubMed  CAS  Google Scholar 

  46. Bidah D, Vergnaud JM. Kinetics of in vitro release of sodium salicylate dispersed in Gelucire. Int J Pharm. 1990;58:215–20.

    Article  CAS  Google Scholar 

  47. Brossard C, Lefort des Ylouses D, Duchene D, Puisieux F, Carstensen JT. Dissolution of a soluble drug substance from vinyl polymer matrices. J Pharm Sci. 1983;72:162–9.

    Article  PubMed  CAS  Google Scholar 

  48. Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm. 2006;309:44–50.

    Article  PubMed  CAS  Google Scholar 

  49. Upadrashta SM, Katikaneni PR, Hileman GA, Keshary PR. Direct compression controlled release tablets using ethylcellulose matrices. Drug Dev Ind Pharm. 1993;19:449–60.

    Article  CAS  Google Scholar 

  50. Pather SI, Russell I, Syce JA, Neau SH. Sustained release theophylline tablets by direct compression. Part 1. Formulation and in vitro testing. Int J Pharm. 1998;164:1–10.

    Article  CAS  Google Scholar 

  51. Yamaoka K, Nakagawa T, Uno T. Application of Akaike’s Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978;6:165–75.

    Article  PubMed  CAS  Google Scholar 

  52. Prema R, Jeevanandham S, Sekar M, Rajkumar T, Dhachinamoorthi D, Chandra Sekhar KB, et al. Studies on fabrication of baclofen sr matrix tablets: in-vitro release pattern overview. Res J Pharm Biol Chem Sci. 2010;1:70–7.

    CAS  Google Scholar 

  53. Ubrich N, Bouillot P, Pellerin C, Hoffman M, Maincent P. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study. J Control Rel. 2004;97:291–300.

    Article  CAS  Google Scholar 

  54. Talukdar MM, Plaizier-Vercammen J. Evaluation of xanthan gum as a hydrophilic matrix for controlled release dosage form preparation. Drug Dev Ind Pharm. 1993;19:1037–46.

    Article  CAS  Google Scholar 

  55. Bhalla H, Sanzgiri YD. An improved controlled release tablet of salbutamol sulphate. Ind J Pharm Sci. 1987;49:22–5.

    CAS  Google Scholar 

  56. Casas JA, Mohedano AF, Garcia-Ochoa F. Viscosity of guar gum and xanthan/guar gum mixture solutions. J Sci Food Agric. 2000;80:1722–7.

    Article  CAS  Google Scholar 

  57. Billa N, Yuen K-H. Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS PharmSciTech. 2000; 1: Article 30.

  58. Neau SH, Chow MY, Durrani MJ. Fabrication and characterization of extruded and spheronized beads containing Carbopol® 974P, NF resin. Int J Pharm. 1996;131:47–55.

    Article  CAS  Google Scholar 

  59. Khouryieh HAM. Rheological characterization of xanthan-guar mixtures in dilute solutions [dissertation]. Manhattan: Kansas State University; 2006.

    Google Scholar 

  60. Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech. 1996;20:64–74.

    Google Scholar 

  61. Draganoiu ES. Evaluation of Kollidon® SR for pH-independent extended release matrix systems [dissertation]. Cincinnati: University of Cincinnati; 2003.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, University of Peshawar, Peshawar, Pakistan

    Muhammad Akhlaq Mughal & Zafar Iqbal

  2. Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, 19104, USA

    Steven Henry Neau

Authors
  1. Muhammad Akhlaq Mughal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zafar Iqbal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven Henry Neau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven Henry Neau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mughal, M.A., Iqbal, Z. & Neau, S.H. Guar Gum, Xanthan Gum, and HPMC Can Define Release Mechanisms and Sustain Release of Propranolol Hydrochloride. AAPS PharmSciTech 12, 77–87 (2011). https://doi.org/10.1208/s12249-010-9570-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-010-9570-1

KEY WORDS

Search

Navigation